Management of acute intracerebral haemorrhage -An update

Zhe Kang Law, Jason P. Appleton, Philip M. Bathc, Nikola Sprigg

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Managing acute intracerebral haemorrhage is a challenging task for physicians. Evidence shows that outcome can be improved with admission to an acute stroke unit and active care, including urgent reversal of anticoagulant effects and, potentially, intensive blood pressure reduction. Nevertheless, many management issues remain controversial, including the use of haemostatic therapy, selection of patients for neurosurgery and neurocritical care, the extent of investigations for underlying causes and the benefi t versus risk of restarting antithrombotic therapy after an episode of intracerebral haemorrhage.

Original languageEnglish
Pages (from-to)166-172
Number of pages7
JournalClinical Medicine, Journal of the Royal College of Physicians of London
Volume17
Issue number2
DOIs
Publication statusPublished - 1 Apr 2017

Fingerprint

Cerebral Hemorrhage
Neurosurgery
Hemostatics
Ambulatory Care
Anticoagulants
Patient Selection
Stroke
Blood Pressure
Physicians
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Management of acute intracerebral haemorrhage -An update. / Law, Zhe Kang; Appleton, Jason P.; Bathc, Philip M.; Sprigg, Nikola.

In: Clinical Medicine, Journal of the Royal College of Physicians of London, Vol. 17, No. 2, 01.04.2017, p. 166-172.

Research output: Contribution to journalArticle

Law, Zhe Kang ; Appleton, Jason P. ; Bathc, Philip M. ; Sprigg, Nikola. / Management of acute intracerebral haemorrhage -An update. In: Clinical Medicine, Journal of the Royal College of Physicians of London. 2017 ; Vol. 17, No. 2. pp. 166-172.
@article{1b0a89504df74896a0c4c382d6637255,
title = "Management of acute intracerebral haemorrhage -An update",
abstract = "Managing acute intracerebral haemorrhage is a challenging task for physicians. Evidence shows that outcome can be improved with admission to an acute stroke unit and active care, including urgent reversal of anticoagulant effects and, potentially, intensive blood pressure reduction. Nevertheless, many management issues remain controversial, including the use of haemostatic therapy, selection of patients for neurosurgery and neurocritical care, the extent of investigations for underlying causes and the benefi t versus risk of restarting antithrombotic therapy after an episode of intracerebral haemorrhage.",
author = "Law, {Zhe Kang} and Appleton, {Jason P.} and Bathc, {Philip M.} and Nikola Sprigg",
year = "2017",
month = "4",
day = "1",
doi = "10.7861/clinmedicine.17-2-166",
language = "English",
volume = "17",
pages = "166--172",
journal = "Clinical Medicine",
issn = "1470-2118",
publisher = "Royal College of Physicians",
number = "2",

}

TY - JOUR

T1 - Management of acute intracerebral haemorrhage -An update

AU - Law, Zhe Kang

AU - Appleton, Jason P.

AU - Bathc, Philip M.

AU - Sprigg, Nikola

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Managing acute intracerebral haemorrhage is a challenging task for physicians. Evidence shows that outcome can be improved with admission to an acute stroke unit and active care, including urgent reversal of anticoagulant effects and, potentially, intensive blood pressure reduction. Nevertheless, many management issues remain controversial, including the use of haemostatic therapy, selection of patients for neurosurgery and neurocritical care, the extent of investigations for underlying causes and the benefi t versus risk of restarting antithrombotic therapy after an episode of intracerebral haemorrhage.

AB - Managing acute intracerebral haemorrhage is a challenging task for physicians. Evidence shows that outcome can be improved with admission to an acute stroke unit and active care, including urgent reversal of anticoagulant effects and, potentially, intensive blood pressure reduction. Nevertheless, many management issues remain controversial, including the use of haemostatic therapy, selection of patients for neurosurgery and neurocritical care, the extent of investigations for underlying causes and the benefi t versus risk of restarting antithrombotic therapy after an episode of intracerebral haemorrhage.

UR - http://www.scopus.com/inward/record.url?scp=85018783850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018783850&partnerID=8YFLogxK

U2 - 10.7861/clinmedicine.17-2-166

DO - 10.7861/clinmedicine.17-2-166

M3 - Article

VL - 17

SP - 166

EP - 172

JO - Clinical Medicine

JF - Clinical Medicine

SN - 1470-2118

IS - 2

ER -